Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 7/20 | 0.36 |
| ▸ | FEN1 | P39748 | 4/20 | 0.35 |
| ▸ | ALOX5AP | P20292 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PTGDR | Q13258 | 3/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CAMKK1 | Q8N5S9 | 1/20 | 0.33 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15681397 | 0.88 | PTGDR2 (0.43) | PTGDR2LMNAHTTPTGDRAPOBEC3G | |
| Ethylene SCHEMBL5076561 | 0.86 | HCRTR2 (0.33) | PTGDR2ALDH1A1MAPT | |
| SCHEMBL19986372 | 0.82 | PTGDR2 (0.40) | PTGDR2FEN1ALOX5APLMNAHTT | |
| SCHEMBL14922531 | 0.80 | KDM1A (0.41) | PTGDR2LMNAHTTAPOBEC3GALDH1A1 | |
| SCHEMBL15684602 | 0.80 | PTGDR2 (0.40) | PTGDR2FEN1ALOX5APPTGDRALDH1A1 | |
| SCHEMBL18949939 | 0.80 | PTGDR2 (0.37) | PTGDR2LMNAHTTPTGDRAPOBEC3G | |
| SCHEMBL15684611 | 0.78 | HTR1D (0.44) | PTGDR2FEN1ALOX5APPTGDR | |
| SCHEMBL26209548 | 0.78 | CAMKK1 (0.36) | PTGDR2FEN1ALOX5APLMNAHTT | |
| SCHEMBL25929345 | 0.78 | CAMKK1 (0.36) | PTGDR2FEN1ALOX5APLMNAHTT | |
| SCHEMBL16768995 | 0.78 | CAMKK1 (0.36) | PTGDR2FEN1ALOX5APLMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1362839-B1 | Liquid crystal composition having a positive delta-epsilon and liquid crystal display device | CHISSO CORP (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-7081279-B2 | Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2006-07-25 | — | — | US | disclosed |
| US-20040065866-A1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2004-04-08 | — | — | US | disclosed |
| EP-1362839-A2 | Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device | CHISSO CORPORATION (JP) | 2003-11-19 | — | — | EP | disclosed |
| EP-0969071-B1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition and liquid crystal display device | CHISSO CORP (JP) | 2003-11-05 | — | — | EP | disclosed |
| EP-0969071-A1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition and liquid crystal display device | CHISSO CORPORATION (JP) | 2000-01-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040065866-A1 | Alkenyl compound having a negative delta epsilon value, liquid crystal composition, and liquid crystal display device | CTNND1, CCT4, DLK1 | PTGDR2 723/4885FEN1 958/4885ALOX5AP 4248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.